Ingram Paul R, Howman Rebecca, Leahy Michael F, Dyer John R
Department of Infectious Diseases, Fremantle Hospital, Fremantle, Western Australia, Australia.
Clin Infect Dis. 2007 Jun 15;44(12):e115-7. doi: 10.1086/518168. Epub 2007 May 2.
Alemtuzumab is a lymphocyte ablative agent that may cause susceptibility to severe opportunistic infections similar to those seen in AIDS. Pathogen-specific immune reconstitution syndromes can complicate antiretroviral therapy and immune recovery in HIV-infected patients. We present the first reported case of immune reconstitution syndrome associated with T lymphocyte recovery after alemtuzumab therapy.
阿仑单抗是一种淋巴细胞清除剂,可能导致患者易患严重的机会性感染,类似于艾滋病患者所见的感染情况。病原体特异性免疫重建综合征可能使HIV感染患者的抗逆转录病毒治疗和免疫恢复复杂化。我们报告了首例经阿仑单抗治疗后与T淋巴细胞恢复相关的免疫重建综合征病例。